|
Neomorph, Inc.
San Diego, USA
|
|
Neomorph is a clinical-stage biotechnology company focused on discovering and developing therapeutics based on targeted protein degradation. The company utilizes a proprietary molecular glue discovery platform to identify small molecules that promote the degradation of specific proteins associated with disease.